Zobrazeno 1 - 10
of 295
pro vyhledávání: '"Lawrence A. Trissel"'
Publikováno v:
American Journal of Pharmaceutical Education. 69:59
Autor:
Lawrence A. Trissel, Pak Chan, Thomas C Kupiec, Vasileios Aloumanis, Michel Ben, Joe Patterson
Publikováno v:
Annals of Pharmacotherapy. 42:1247-1251
Background Esomeprazole sodium (Nexium IV, AstraZeneca) is the S-isomer of omeprazole and acts as a proton pump inhibitor gastric antisecretory agent indicated for the short-term treatment of gastroesophageal reflux disease in patients with a history
Autor:
Lawrence A. Trissel, Yanping Zhang
Publikováno v:
Annals of Pharmacotherapy. 40:1289-1292
Background: Pemetrexed is a multitargeted antifolate antineoplastic agent indicated for single-agent use in advanced or metastatic non–small-cell lung cancer and in combination with cisplatin for the treatment of malignant pleural mesothelioma not
Autor:
Yanping Zhang, Lawrence A. Trissel
Publikováno v:
Annals of Pharmacotherapy. 40:1082-1085
Background: Pemetrexed is a multitargeted, antifolate, antineoplastic agent that is indicated for single-agent use in locally advanced or metastatic non-small-cell lung cancer after prior chemotherapy and in combination with cisplatin for the treatme
Publikováno v:
American Journal of Health-System Pharmacy. 62:834-837
Anidulafungin (Vicuron Pharmaceuticals, King of Prussia, PA), a novel investigational antifungal, is in a unique molecular class known as echinocandins.[1][1] Anidulafungin is a broad-spectrum antifungal and has activity against strains resistant to
Autor:
Lawrence A, Trissel
Publikováno v:
International journal of pharmaceutical compounding. 16(1)
Lawrence A. Trissel was awarded the 2011 Institute for Safe Medication Practices Lifetime Achievement Award. In this article, the author acknowledges his appreciation of being selected for this award, pays his respects to those who honored him, and d
Autor:
Lawrence A. Trissel, Yanping Zhang
Publikováno v:
Journal of Oncology Pharmacy Practice. 10:191-195
The objective of this study was to evaluate the physical and chemical stability of undiluted palonosetron HCl 50 mcg/mL with cisplatin 0.5 mg/mL, carboplatin 5 mg/mL, and with oxaliplatin 0.5 mg/mL in infusion solutions during simulated Y-site admini
Publikováno v:
American Journal of Health-System Pharmacy. 61:2289-2293
PURPOSE: The physical compatibility of pemetrexed disodium with selected other drugs during simulated Y-site injection was studied. METHODS: A 5 mL sample of pemetrexed disodium 20 mg/mL in 0.9% sodium chloride injection was combined with 5 mL of a s
Autor:
Lawrence A. Trissel, Quanyun A Xu
Publikováno v:
Annals of Pharmacotherapy. 38:1608-1611
BACKGROUND Palonosetron HCl is a selective 5-HT3 receptor antagonist used for the prevention of chemotherapy-induced nausea and vomiting. Palonosetron HCl may be diluted in an infusion solution for administraton. Consequently, stability information i
Autor:
William C. Satterfield, Mary Johansen, Tamara Lee Gradert, Keith R. Hildebrand, Lawrence A. Trissel, Samuel J. Hassenbusch, Wallace B. Baze
Publikováno v:
Anesthesia & Analgesia. :1528-1535
UNLABELLED We investigated the safety of midazolam administered by continuous intrathecal infusion in relevant animal models. Preservative-free midazolam was delivered to sheep and pigs by using implanted infusion systems (SynchroMed pumps plus silic